Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: US BIOLOGIC, INC.
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2021-07-19 to 2023-08-31
Current total value of award: $664774
Description: US BIOLOGIC R&D FOR THE DEVELOPMENT OF A RAPID-RESPONSE ORAL INFLUENZA VACCINE (AOI #6 BTN)